Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and <i>In situ</i> Hybridization Analysis
Kay Savage(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Chris Jones(North Carolina State University), Robin L. Jones(Institute of Cancer Research), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Alan Ashworth(University of California, San Francisco), Alan Mackay(Institute of Cancer Research), Jason L. Hornick(Harvard University), Michelle A. James(Shriners Hospitals for Children - Erie), David Robertson(Institute of Cancer Research), Maryou Lambros(Institute of Cancer Research), Fernando Schmitt(Universidade do Porto), Emílio Marcelo Pereira, Fernanda Milanezi(Universidade do Porto)
Cited by 208
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k